LFMDP
LifeMD, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$23.50
+0.04%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$32.90M
MomentumView details →
1D Return
+0.04%
YTD Return
+6.62%
RSI (14)
55.0
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−1.0x
Market Cap
$32.90M
RSI (14)
55.0
MomentumView details →
1D Return
+0.04%
YTD Return
+6.62%
Similar companies
Latest newsMore news →
LifeMD reported second quarter 2026 revenue of $47.3 million and an adjusted EBITDA loss of approximately $3.5 million, improving about 21% sequentially.30d agoLifeMD, Inc. declared a quarterly cash dividend of $0.5546875 per share on its Series A Cumulative Perpetual Preferred Stock, payable on July 15, 2026 to holders of record on July 3, 2026.73d ago